News from regulus therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 28, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jun 04, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Initiates Phase I Clinical Study of RG-012, a microRNA Therapeutic in Development for the Treatment of Alport Syndrome

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Jun 01, 2015, 17:58 ET
Regulus Therapeutics Inc. Logo

Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

May 07, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Reports First Quarter 2015 Financial Results and Recent Highlights

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 30, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 29, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at the Deutsche Bank 40th Annual Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 25, 2015, 11:45 ET
Regulus Therapeutics Inc. Logo

Late-Breaking Oral Presentation at The International Liver Congress™ (ILC 2015) Highlights RG-101's Potent, Durable and Pan-Genotypic Effects in Diverse HCV Population

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 09, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus to Present Late-Breaking, Expanded RG-101 Data Set for the Treatment of HCV at The International Liver Congress™ 2015 (ILC 2015)

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Apr 07, 2015, 16:10 ET
Regulus Therapeutics Inc. Logo

RG-125 (AZD4076), a microRNA Therapeutic Targeting microRNA-103/107 for the Treatment of NASH in Patients with Type 2 Diabetes/Pre-Diabetes, Selected as Clinical Candidate by AstraZeneca

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines...

Mar 25, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Receives Orphan Medicinal Product Designation from the European Commission for RG-012, a microRNA Therapeutic in Development for the Treatment of Alport Syndrome

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 26, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at Cowen and Company 35th Annual Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 19, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at 2015 RBC Capital Markets' Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 18, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 12, 2015, 17:09 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Timing for Fourth Quarter and Year-End 2014 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 09, 2015, 07:00 ET
Regulus Therapeutics Inc. Logo

All HCV Patients Treated with a Single SC Administration of 4 mg/kg of RG-101 Responded with Mean Viral Load Reduction of 4.8 log10 at Day 29 and 9/14 Patients are Below the Limit of Quantification at Day 57

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 02, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at Two Upcoming Investor Conferences

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 02, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Earns Milestone Payment from Biogen Idec Related to the Identification of Potential microRNA Biomarkers in Multiple Sclerosis

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced...

Jan 08, 2015, 08:00 ET

Regulus Announces Key Goals Under its 'Clinical Map Initiative' for 2015

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 26, 2014, 16:05 ET

Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 15, 2014, 18:00 ET